Jens Ulrik Holst
Keine laufenden Positionen mehr
Karriereverlauf von Jens Ulrik Holst
Ehemalige bekannte Positionen von Jens Ulrik Holst
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Arlington Capital Investors Ltd.
 Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | Mitglied des Investmentausschusses | 01.09.2003 | 01.02.2010 |
| Vertrieb & Marketing | 01.09.2003 | 01.02.2010 | |
Origio A/S
 Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Vorsitzender | 31.03.2010 | 31.03.2010 |
Ausbildung von Jens Ulrik Holst
| University of Mannheim | Masters Business Admin |
Statistik
International
| Vereinigtes Königreich | 2 |
| Deutschland | 2 |
| Dänemark | 2 |
Operativ
| Investment Committee Member | 1 |
| Sales & Marketing | 1 |
| Masters Business Admin | 1 |
Sektoral
| Finance | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Arlington Capital Investors Ltd.
Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | Finance |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Health Technology |
- Börse
- Insiders
- Jens Ulrik Holst
- Erfahrung
